Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 17Stomach Neoplasms 14Rectal Neoplasms 10Pancreatic Neoplasms 7Colonic Neoplasms 6Biliary Tract Neoplasms 5Adenocarcinoma 4HER2-positive Gastric Cancer 3Esophageal Neoplasms 3Cholangiocarcinoma 3Ovarian Neoplasms 2Neoplasms 2Lymphoma, Extranodal NK-T-Cell 2Locally Advanced Gastric Cancer 2Cirrhosis, Familial, with Pulmonary Hypertension 2Carcinoma, Non-Small-Cell Lung 2Carcinoma, Hepatocellular 2Spinocerebellar Degenerations 1Rectal Neoplasms Malignant 1Preventive Effect of Quintuple Therapy on Metachronous Liver Metastases in Patients With Colorectal Cancer 1Pathologic Complete Response 1Pancreatic Cancer Resectable 1PDAC - Pancreatic Ductal Adenocarcinoma 1Neoplasm, Residual 1Neoplasm Metastasis 1Neoadjuvant Chemotherapy 1MSI-H Colorectal Cancer 1Locally Advanced Rectal Cancer (LARC) 1Locally Advanced Rectal Cancer 1Locally Advanced Low Rectal Adenocarcinoma 1

Interventions

Gemcitabine 2sintilimab 1Taxes 1Oxaliplatin 1Leucovorin 1Irinotecan 1Fluorouracil 1Capecitabine 1130-nm albumin-bound paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Pancreatic Cancer Resectable × Oxaliplatin × Clear all
NCT07155629 2025-09-04

LEFT-PANC

Helsinki University Central Hospital

Phase 3 Not yet recruiting
381 enrolled
Gastrointestinal

Pancreatic Cancer Resectable

Data powered by HemOnc (CC BY 4.0) Colophon âš¡